| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |